Trials / Completed
CompletedNCT00441883
Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma
A Phase 2, 28 Day Parallel-Group, Double-Masked, Dose-Finding Study Comparing the Safety and Efficacy of PF-03187207 to Latanoprost
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 176 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of PF 03187207.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PF-03187207 and Latanoprost Vehicle | |
| DRUG | Latanoprost 0.005% and PF-03187207 Vehicle |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2008-02-01
- Completion
- 2008-07-01
- First posted
- 2007-03-01
- Last updated
- 2020-09-14
- Results posted
- 2020-08-27
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00441883. Inclusion in this directory is not an endorsement.